Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 887
Guide Official Revision Description Reason for Update
Version Date Number Of Change
within classes of
medications.
2017 04/26/2017 1. Medical Policy In Disease Protocols -
Coronary Heart Disease
(CHD), Disease Protocols -
Valve Replacement, and
Disease Protocols – Cardiac
Transplant, revised language
to remove reference to
mandatory wait time for third
class, per Public Law 114-
190, Sec. 2307. Note: 49
USC 44703 note. Medical
Certification of Certain Small
Aircraft Pilots.
2017 04/26/2017 2. Medical Policy Revised language In
Pharmaceuticals –
Glaucoma Medications, Item
31. Eye, and CACI –
Glaucoma Worksheet.
Applicants using miotic or
mydriatic eye drops or taking
an oral medication for
glaucoma may be
considered for Special
Issuance certification
following their demonstration
of adequate control. These
medications do not qualify
for the CACI program.
2017 04/07/2017 1. Administrative In Item 47. Psychiatric
Conditions, Use of
Antidepressant Medications,
revised Airman Information –
SSRI INITIAL Certification
sheet to clarify information
regarding submitting
package to the FAA.
2017 04/07/2017 2. Administrative In Item 47. Psychiatric
Conditions, Use of
Antidepressant Medications,
revised HIMS AME Checklist
– SSRI Recertification/Follow
Up Clearance to correct the
address.
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
